, /PRNewswire/ — Clearway Health, based in Boston, and Saint Peter’s Healthcare System, based in New Brunswick, New Jersey, announced a new strategic plan to open and operate a specialty pharmacy. Targeted to open in late 2025, the specialty pharmacy will ensure Saint Peter’s patients have equitable access to vital specialty medications and the ongoing care and support needed to manage complex medical conditions such as cancer and hepatitis C. Additionally, the partnership will improve patient access to new medications currently limited by manufacturers or payors.
To strengthen medication management, adherence and improve overall clinical outcomes for patients on specialty medication therapies, certified pharmacists and skilled specialty pharmacy patient liaisons will be embedded directly into the care teams in several of Saint Peter’s outpatient practices, including gastroenterology, rheumatology, and adult and pediatric endocrinology, as well as pulmonary, infectious disease and pediatric neurology. This team will work to proactively identify patients, assess barriers that may prevent …